Avalo Therapeutics Inc. (AVTX)
NASDAQ: AVTX
· Real-Time Price · USD
9.76
-0.12 (-1.21%)
At close: Aug 25, 2025, 11:29 AM
AVTX Gamma Exposure By Expiry
The total Gamma Exposure (GEX) for AVTX across all expirations is 21.15 shares per 1% move, with 37.05 from calls and 15.9 from puts. The put-call GEX ratio of 0.43 shows call-heavy positioning, potentially creating volatility as market makers hedge by selling into strength and buying weakness. The highest gamma concentration is at the Nov 21, 25 expiration with 28.91 net GEX, which may act as a magnet point for price action. Near-term exposure for Sep 19, 25 suggests possible volatility from negative gamma effects.
AVTX GEX Table
| Expiry Date | Call GEX | Put GEX | Net GEX | P/C GEX |
|---|---|---|---|---|
| Sep 19, 25 | 2.85 | -12.24 | -9.39 | 4.29 |
| Oct 17, 25 | 0.67 | -0.05 | 0.62 | 0.07 |
| Nov 21, 25 | 29.66 | -0.75 | 28.91 | 0.03 |
| Feb 20, 26 | 3.87 | -2.86 | 1.01 | 0.74 |